Does TADALAFIL Cause Malignant melanoma? 741 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 741 reports of Malignant melanoma have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 2.4% of all adverse event reports for TADALAFIL.
741
Reports of Malignant melanoma with TADALAFIL
2.4%
of all TADALAFIL reports
35
Deaths
32
Hospitalizations
How Dangerous Is Malignant melanoma From TADALAFIL?
Of the 741 reports, 35 (4.7%) resulted in death, 32 (4.3%) required hospitalization.
Is Malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 741 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
TRAMETINIB DIMETHYL SULFOXIDE (281)
Which TADALAFIL Alternatives Have Lower Malignant melanoma Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR